After launching its first liquid biopsy service in Europe earlier this year, the cancer test developer Guardant Health has taken new steps to offer its comprehensive genomic profiling technology in China.
[Fierce Biotech]
Home Newsletters Intestinal Cell News Guardant Health Takes Its Cancer Blood Tests to China through Clinical Trial...
